El diagnóstico de la infección por el virus de la hepatitis C en España: una oportunidad para mejorar
Tài liệu tham khảo
2017, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study, Lancet Gastroenterol Hepatol., 2, 161, 10.1016/S2468-1253(16)30181-9
WHO guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO [consultado 28 Ene 2018]. Disponible en: https://www.finddx.org/wp-content/uploads/2017/02/WHO-guidelines-HBV-HCV-testing-Feb2017.pdf
Lavin, 2017, Prevalence of hepatitis C in the Spanish population. The prevhep study (ETHON cohort), J Hepatology, 66, S272, 10.1016/S0168-8278(17)30857-7
Rodríguez-Tajesa S, Dacalb Y, Collazos C, Frías MC, Vidal Benedee MJ, Janéd M, et al. Estudio de prevalencia de infección por los virus de la hepatitis B y C en Cataluña. 42 Congreso de la Asociación Española de Estudio del Hígado. Madrid, 15-17 de febrero de 2017.
Li, 2017, Current therapy for chronic hepatitis C: The role of direct-acting antivirals, Antiviral Res., 142, 83, 10.1016/j.antiviral.2017.02.014
2017, EASL recommendations on treatment of hepatitis C 2016, J Hepatol., 66, 153, 10.1016/j.jhep.2016.09.001
2015, Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus, Hepatology., 62, 932, 10.1002/hep.27950
World Health Organisation, 2017a. Hepatitis C fact sheet [consultado 29 Ene 2018]. Disponible en: http://www.who.int/mediacentre/factsheets/fs164/en/
Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO [consultado 29 Ene 2018]. Disponible en: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf
Buti, 2017, Eliminación de la hepatitis C en España: Adaptación de un modelo matemático de salud pública partiendo del plan estratégico para el abordaje de la hepatitis C en el Sistema Nacional de Salud, Med Clin (Barc)., 148, 277, 10.1016/j.medcli.2016.12.018
The Lancet. Eliminating viral hepatitis: time to match visions with action. Lancet. 2017;390:2121.
National Academies of Sciences, Engineering, and Medicine. A national strategy for the elimination of hepatitis B and C: Phase two report. Washington, DC: The National Academies Press; 2017.
Ministerio de Sanidad, Servicios Sociales e Igualdad. Plan estratégico para el abordaje de la hepatitis C en el sistema nacional de salud. Madrid, 21 de mayo de 2015.
Denniston, 2014, Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010, Ann Intern Med., 160, 293, 10.7326/M13-1133
Grebely, 2017, Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: A cohort study, Lancet Gastroenterol Hepatol., 2, 514, 10.1016/S2468-1253(17)30075-4
Peeling, 2017, The future of viral hepatitis testing: Innovations in testing technologies and approaches, BMC Infect Dis., 17, 699, 10.1186/s12879-017-2775-0
Grebely, 2017, Hepatitis C point-of-care diagnostics: In search of a single visit diagnosis, Expert Rev Mol Diagn., 17, 1109, 10.1080/14737159.2017.1400385
Assoumou, 2018, Cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings, Clin Infect Dis., 66, 376, 10.1093/cid/cix798
Chhatwal, 2018, Hepatitis C screening: From modeling to public health policy, Clin Infect Dis., 66, 385, 10.1093/cid/cix800
Ministerio de Sanidad, Servicios Sociales e Igualdad. Catálogo Nacional de Hospitales 2017. Actualizado a 31 de diciembre de 2016 [consultado 11 Jul 2017]. Disponible en: https://www.msssi.gob.es/ciudadanos/prestaciones/centrosServiciosSNS/hospitales/home.htm
Harris, 2016, Finding the undiagnosed: A qualitative exploration of hepatitis C diagnosis delay in the United Kingdom, J Viral Hepat., 23, 479, 10.1111/jvh.12513
Yau, 2015, Rate, delay and predictors of hepatitis C treatment in British Columbia, Can J Gastroenterol Hepatol., 29, 315, 10.1155/2015/120132
Levi, 2016, Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project, Eur J Public Health., 26, 561, 10.1093/eurpub/ckw054
Casas, 2017, Diagnóstico del virus de la hepatitis C: impacto de la actitud del servicio de Microbiología en la cascada del tratamiento, Enferm Infecc Microbiol Clin., 35, 237
Greenaway, 2017, A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada, BMC Infect Dis., 17, 140, 10.1186/s12879-017-2242-y
Grassi, 2017, Hepatitis C in injection drug users: It is time to treat, World J Gastroenterol., 23, 3569, 10.3748/wjg.v23.i20.3569
Konerman, 2016, Hepatitis C treatment and barriers to eradication, Clin Transl Gastroenterol., 7, e193, 10.1038/ctg.2016.50
Parry, 2017, One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling, BMC Infect Dis., 17, 705, 10.1186/s12879-017-2774-1
Rogal, 2017, The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample, Implement Sci., 12, 60, 10.1186/s13012-017-0588-6
Clark, 2005, Hepatitis C identification and management by family physicians, Fam Med., 37, 644
Alados, 2017, Situación actual del diagnóstico de la infección por el virus de la hepatitis C en Andalucía, Enferm Infecc Microbiol Clin., 35, 25